A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

Duration of Response(DOR)

Time from the date of first partial remission or complete remission to the date of disease progression, or death of any cause, or date of lost follow-up, whichever comes first, otherwise subject data were censored at time last known disease free.

Time frame: up to approximately 3 years

Disease Control Rate(DCR)

Complete remission rate+ partial remission rate+stable disease rate

Time frame: up to approximately 3 years

Time to response(TTR)

Time from the initiation of the treatment to the first remission

Time frame: up to approximately 3 years

Progression Free Survival(PFS)

Time from the date of enrollment to of disease progression, or death of any cause, or date of lost follow-up, whichever comes first, otherwise subject data were censored at time last known disease free.

Time frame: up to approximately 3 years

Overall survival(OS)

Time from the date of enrollment to data of death from any cause, or date of lost follow-up, whichever comes first, and otherwise censored at time last known alive.

Time frame: up to approximately 3 years